NEW MJ NEWS

Reliq Health Technologies, Inc. to Participate in the Healthcare IT Virtual Conference Part II Presented by Maxim Group LLC and Hosted by M-Vest, June 1st, 2023

Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that its CEO, Dr. Lisa Crossley, has been invited to present at the Healthcare IT Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, on Thursday, June 1st, 2023.

Allen Klee, Research Analyst at Maxim Group, will sit down with Healthcare IT companies at the conference to discuss solutions to improve health care outcomes and lower costs. The healthcare system faces pressure from labor shortages, higher costs, lack of transparency, and managing reimbursements. This conference highlights companies that provide solutions with the use of telehealth, at home monitoring, specific chronic conditions treatment programs, marketplaces that create better pricing, and use of AI.

This conference will be live on M-Vest beginning at 9:00am EDT on June 1st. To attend, sign up to become an M-Vest member at this link: https://m-vest.com/events/healthcare-it-06012023.

Reliq Health
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

For further information please contact:

Company Contact
Investor Relations at ir@reliqhealth.com

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company”) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting

Meeting Highlights Include New Phase 3 Data for EPIDIOLEX in Tuberous Sclerosis…

 Next Green Wave Holdings Inc. (NGW) (NXGWF) Receives City Council Approval To Move Forward With Second Facility

City Approval of Conditional Use Permits for Next Green Wave’s Extraction and…

Tetra Bio-Pharma Inc (TBPMF) Provides Extension to North Bud Farms

Tetra Bio-Pharma Provides Extension to North Bud Farms Tetra Bio-Pharma Inc., a…

$NRTI to Attend Hy-Vee Company-Wide General Merchandise Show on March 11, 2015

Inergetics to Attend Hy-Vee Company-Wide General Merchandise Show on March 11, 2015…